Is it purely glucose control
Plaintiffs in the MDL allege that manufacturers, including Novo Nordisk and Eli Lilly, failed to provide timely and adequate warnings about gallbladder risks despite emerging clinical data and post-market adverse event reports
Discard the pen immediately if the solution appears cloudy, contains visible particles, or shows signs of discolorationsemaglutide should always be clear and colorless
The injection is subcutaneous given under the skin, usually in the abdomen, thigh, or upper arm
The country is an enticing market for companies selling weight loss medicines, as it has the highest prevalence of obesity in Sub-Saharan Africa
This pharmacokinetic profile means that dose adjustments are generally not required in patients with renal impairment, although clinical experience in end-stage renal disease (ESRD) and dialysis is limited, so caution and monitoring are advised in these populations